Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from MarketBeat

Teva Pharma: Why This Generic Drug Giant Is a Smart Buy Now

Teva Pharmaceuticals is the world's largest generic drug maker with over 500 generics in its portfolio, but shares sold off on its recent earnings, buying opp?

Big Dividend Hikes: 4 Large-Cap Stocks Increasing Payouts

Big Dividend Hikes: 4 Large-Cap Stocks Increasing Payouts

These four large-cap stocks, three of which are S&P 500 members, are raising their quarterly dividend payments to kick off 2025.

Procter & Gamble: A Consumer Staples Titan Built to Win

Procter & Gamble: A Consumer Staples Titan Built to Win

Proctor & Gamble is a manufacturer of brand name grooming, baby, personal , cleaning and hygiene products that's sending consumers are spending again for brands

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Sector Rotation: Are Utilities Gaining as Financials Weaken?

The utility sector is up 2.89% YTD, lagging financials but maintaining positive sentiment, with technicals showing a potential breakout near $80.

3 Stocks Benefiting from the 'Returnuary' Shopping Wave

January has been dubbed "Returnuary" as shoppers return holiday gifts after a strong holiday shopping season. Most retailers dread this month, but some win big.

Can Palladyne AI Live Up to the Hype?

Palladyne AI was one of the hottest stocks in 2024, surging by about 1,600%; while there are reasons to support the hype, there are also reasons to be cautious.

3X-Leveraged ETFs: Amplify Returns With These 3 Top Picks

Leveraged ETFs are not designed for casual or buy-and-hold investors due to their heightened risk; however, for experienced investors they can be a strong play.

inkl

Read news from The Economist, FT, and more,
with one subscription

Reshoring Riches: Investing in Made in America 2.0

Reshoring Riches: Investing in Made in America 2.0

Global shifts are reshaping manufacturing leading to a resurgence of American industry and significant investment opportunities in key sectors.

3 REITs to Watch as Interest Rates Keep Falling

3 REITs to Watch as Interest Rates Keep Falling

REITs make a strong choice during periods of relatively low interest rates thanks to their reliance on debt and their dividend payouts.

3 Stocks to Gain From Trump’s Return-to-Office Mandate

3 Stocks to Gain From Trump’s Return-to-Office Mandate

Thousands of Federal government office workers are called back to the office ending remote work, but these stocks are poised to gain from the extra business.

Crane Stock Soars, But the Best Could Be Yet to Come: Here's Why

Crane Stock Soars, But the Best Could Be Yet to Come: Here's Why

Crane Company stock is flying high but can continue to increase because of growth, improving earnings quality, and analysts' sentiment trends.

MarketBeat Week in Review – 01/27 - 01/31

Stocks posted slight gains for the week as investors shrugged off concerns over China's DeepSeek open-source API and the latest reading on inflation

AbbVie Investors Trigger Trend-Following Signal: Time to Load Up

AbbVie Investors Trigger Trend-Following Signal: Time to Load Up

AbbVie is on track to sustain growth in the wake of Humira's patent cliff and the forecasts are too low. Investors can look forward to an upgrade cycle in 2025.

Whirlpool: Buy This High-Yielding Value Before It Spins Higher

Whirlpool: Buy This High-Yielding Value Before It Spins Higher

Whirlpool's transition repositioning gain traction and allowed for significant improvement in shareholder value; buy this deep-value while its down.

Get all your
news in one place.

100’s of premium titles.
One news app.

Commvault Systems: Share Price Primed to Vault Higher in 2025

Cyber security firm Commvault is outperforming and increasing guidance quarterly, driving a positive trend in analysts' sentiment and institutional buying.

Starbucks’ CEO-Led Turnaround Gains Traction: New Highs Likely

Starbucks Q1 wasn't a game-changer but aligns with the outlook for growth to resume in Q2 and improve sequentially as Brian Niccol's turnaround gains traction.

Meta’s AI & Smart Glasses Could Drive 20%+ Upside in 2025

Meta Platforms is emerging as a leader in AI application and an enduring consumer technology company. Its Ray-Ban smart glasses are gaining traction.

Microsoft Stock Breaks Trend, But It Doesn’t Matter—Here’s Why

Microsoft's Q2 results hint at the robust outlook for AI services industry growth, expected to sustain a 36% CAGR through the middle of the next decade.

Get all your
news in one place.

100’s of premium titles.
One news app.

ASML: Strengths and Upside Remain Despite DeepSeek Worries

ASML is one company that can provide substantial insight into the overall health of the semiconductor industry. It did not disappoint in its latest results.

Royal Caribbean Soars, But Smooth Sailing Isn’t Guaranteed

Royal Caribbean stock is up sharply after posting strong profits and raising guidance, but investors may concerns that RCL stock is pricing in future growth

Kimberly-Clark: A Regal Opportunity in This Dividend King

Kimberly-Clark's high-yielding dividend is safe for 2025 and likely to grow at the end of the fiscal year. A turn-around is in process and gaining traction.

High-Yield Texas Instruments Poised to Rebound in 2025

Texas Instruments' blue-chip business is solid and provides sufficient cash flow to maintain a fortress balance sheet while paying a higher-than-average yield.

Sizing Up a New Opportunity for NVIDIA Investors

NVIDIA's stock price plunge is a deep value opportunity for investors seeking exposure to the leading AI player globally.

GeneDx: Even After Up 2,700% in 2024, Upside Is Still in Play

Saying shares of GeneDx skyrocketed in 2024 may be an understatement. As a leader in its market, upside is still a legitimate possibility for this name.

Health-Tech Revival: 3 Stocks Set for a Big 2025 Rebound

Check out these three health-tech stocks with prospects of recovery in 2025 after seeing shares decline significantly in 2024.

1 … 72 73 74 75

People

128,412 stories

Gabriel OsorioMazilli

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Royal Caribbean

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

288,202 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play